GU Cancers 2022 | Unmet needs in the use of circulating tumor cells for prostate cancer

Giulio Francolini, MD, University of Florence, Florence, Italy, talks on the characterisation of circulating tumor cells and why improvements in this area can lead to a better understanding of each patient’s individual disease. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.